Wardrop, D., Estcourt, L., Doree, C., Hopewell, S., Brunskill, S., Stanworth, S., & Murphy, M. (2016). Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol). Cochrane Collaboration.
Chicago Style (17th ed.) CitationWardrop, D., L. Estcourt, C. Doree, S. Hopewell, S. Brunskill, S. Stanworth, and M. Murphy. Anti-fibrinolytics (lysine Analogues) for the Prevention of Bleeding in Patients with Haematological Disorders (Protocol). Cochrane Collaboration, 2016.
MLA (9th ed.) CitationWardrop, D., et al. Anti-fibrinolytics (lysine Analogues) for the Prevention of Bleeding in Patients with Haematological Disorders (Protocol). Cochrane Collaboration, 2016.
Warning: These citations may not always be 100% accurate.